• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS FT4 III ASSAY; RADIOIMMUNOASSAY, FREE THYROXINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS FT4 III ASSAY; RADIOIMMUNOASSAY, FREE THYROXINE Back to Search Results
Model Number FT4 G3
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/07/2021
Event Type  malfunction  
Manufacturer Narrative
The investigation is ongoing.
 
Event Description
The initial reporter received questionable elecsys ft4 iii assay results for one patient tested on a cobas 8000 e 801 module serial number (b)(4).The patient's initial ft4 result was reported outside the laboratory.The physician asked for a re-measurement of the patient's sample.The customer performed repeat testing on an accuraseed analyzer.The patient's sample was sent outside the laboratory for further testing on a cobas 8000 e 801 module and an abbott architect.
 
Manufacturer Narrative
The customer's calibration, qc, sample pre-analytical details, and system alarm trace were requested but not provided.The patient's sample was provided for an investigation.The investigation tested the patient's sample on a cobas 8000 e 801 module and the ft4 result was 1.80 ng/dl and the tsh result was 0.083 uiu/ml.The investigation reproduced the customer's ft4 and tsh result.The observed differences in ft4 values generated with the roche assay and the abbott assay are most likely caused by differences in the overall setups of the assays, the antibodies used, differences in reference materials, and the differences in the standardization methodology used.For the assay tsh, an interferent against a component of the reagent was confirmed, ruthenium label.This interference is covered in product labeling: per product labeling, "in rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur.These effects are minimized by suitable test design.For diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other findings." the investigation did not identify a product problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS FT4 III ASSAY
Type of Device
RADIOIMMUNOASSAY, FREE THYROXINE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key12302494
MDR Text Key266006274
Report Number1823260-2021-02329
Device Sequence Number1
Product Code CEC
Combination Product (y/n)N
PMA/PMN Number
K131244
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 09/28/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberFT4 G3
Device Catalogue Number07976887190
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 07/26/2021
Initial Date FDA Received08/10/2021
Supplement Dates Manufacturer Received09/08/2021
Supplement Dates FDA Received09/28/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-